Introduction {#s1}
============

Asthma is a common chronic respiratory inflammation disease associated with airway hyperreactivity, reversible airway obstruction, mucus hypersecretion, inflammatory cell migration, bronchial epithelial desquamation, and airway wall remodeling [@pone.0090460-Seidel1], [@pone.0090460-Richter1]. It is a complex disorder caused by both genetic and environmental factors. Over 100 genes have been reported to be associated with asthma risk and related phenotypes [@pone.0090460-Weiss1], [@pone.0090460-Zhang1].

The regulated on activation, normal T cell expressed and secreted (RANTES), a member of the CC chemokine family, is a potent eosinophil, monocyte, basophile and lymphocyte chemo-attractant. It had close correlations with the attraction and recruitment of lymphocytes, monocytes, basophils and eosinophils to the places of inflammation, and thus, was involved in various inflammatory and immune disorders, including asthma [@pone.0090460-Alam1], [@pone.0090460-Kameyoshi1], [@pone.0090460-Lewis1]. Two RANTES promoter polymorphisms of −403 G/A and −28C/G were demonstrated to affect the promoter activity and increase the expression of RANTES [@pone.0090460-Liu1].

Although numerous studies have demonstrated the correlation between RANTES (−403G/G and −28C/C) polymorphisms and asthma, the results still remains inconsistent. Therefore, this meta-analysis was performed currently to observe the association of these two polymorphisms with asthma risk, which firstly provided the updated meta-analysis of comprehensive studies about RANTES gene polymorphisms and asthma.

Methods {#s2}
=======

2.1 Search strategy {#s2a}
-------------------

Two independent reviewers searched Pubmed, Embase, and Cochrane library databases systemically and extensively to obtain the case-control genetic association of RANTES polymorphisms and asthma studies without any language restrictions. The Medical Subject Heading (MeSH) and keyword terms "RANTES", "CCL5", "asthma", and "polymorphism" were used as search criteria.

2.2 Study selection and data abstraction {#s2b}
----------------------------------------

The inclusion criteria for the gene association studies in this meta-analysis were as follows: 1) case-control studies and cohort studies; 2) original data on genotype and allele distributions and frequencies were available for case and control subjects; 3) genotype distributions of the controls were in Hardy-Weinberg equilibrium. Data abstraction was performed by two independent reviewers as mentioned above.

2.3 Statistical analysis {#s2c}
------------------------

Chi-square test was used to determine whether the genotype distributions of the controls were in Hardy-Weinberg equilibrium. Heterogeneity between studies was tested with both Cochran\'s test and *I^2^* statistics. P\<0.1 or *I^2^*\>50% indicated significant heterogeneity in this study [@pone.0090460-Higgins1]. Publication bias was assessed by funnel plot and Egger\'s regression test [@pone.0090460-Egger1]. Data of this meta-analysis were analyzed by Stata software (Version 12.0; Stata Corporation, College Station, TX). P-value \<0.05 were considered statistically significant.

Results {#s3}
=======

By searching Pubmed, Embase, and Cochrane library databases systemically and extensively, one was excluded because of unavailable data [@pone.0090460-Liu2]. A total of 18 case-control and cohort studies with usable data met the inclusion criteria and were enrolled in this meta-analysis, including 14 articles on −403 G/A, and 14 on −28C/G [@pone.0090460-Szalai1]--[@pone.0090460-Kaneko1]. The included studies provided 2558 cases and 2630 controls of −403 G/A, as well as 3311 cases and 4031 controls of −28C/G for this analysis. The characteristics of included studies in this present meta-analysis were showed in [Table 1](#pone-0090460-t001){ref-type="table"} and [Table 2](#pone-0090460-t002){ref-type="table"}.

10.1371/journal.pone.0090460.t001

###### Characteristics of included studies in the meta-analysis for the −403G/A polymorphism.

![](pone.0090460.t001){#pone-0090460-t001-1}

  First Author (Ref)    Year   Sample size (case/control)   Case genotypes   Control genotypes
  -------------------- ------ ---------------------------- ---------------- -------------------
  Fryer (19)            2000             120/74                75/39/6            51/21/2
  Szalai (12)           2001            164/303                122/32/6          211/84/8
  Hizawa (13)           2002            298/311               146/108/44        140/137/34
  Yao (14)              2003            182/107                98/65/19           60/41/6
  Liu (21)              2005             32/32                 17/13/2            16/14/2
  Leung (17)            2005             129/66                60/53/16           37/21/8
  Moissidis (18)        2005             61/131                16/34/11          35/72/24
  Al-Abdulhadi (16)     2005            162/291                47/98/17         166/104/21
  Lachheb (23)          2007            210/224               140/50/20          174/40/10
  Sohn (24)             2008            326/253               109/146/71         97/107/49
  Tölgyesi G (22)       2006            144/174                107/34/3          131/40/3
  Muro (25)             2008            306/242               202/93/11          165/69/8
  Nahas (27)            2012             40/38                 30/10/0            30/8/0
  Liu (27)              2013            384/384               148/186/50        149/183/52

10.1371/journal.pone.0090460.t002

###### Characteristics of included studies in the meta-analysis for the −28C/G Polymorphism.

![](pone.0090460.t002){#pone-0090460-t002-2}

  First Author (Ref)    Year   Sample size (case/control)   Case genotypes   Control genotypes
  -------------------- ------ ---------------------------- ---------------- -------------------
  Szalai (12)           2001            164/303                144/16/0          284/19/0
  Hizawa (13)           2002            298/311               216/70/12          243/62/6
  Yao (14)              2003            182/107                134/39/9           83/23/1
  Wang (15)             2004             100/90                65/31/4            72/17/1
  Huang (20)            2005            251/107                189/53/9           83/23/1
  Moissidis (18)        2005             61/129                 59/2/0            129/0/0
  Liu (21)              2005             32/32                  25/6/1            29/3/0
  Lachheb (23)          2007            210/224               163/35/12          190/29/5
  Muro (25)             2008            306/242                289/17/0          228/14/0
  Sohn (24)             2008            326/253               218/93/15          174/66/13
  Murk (26)             2011            100/482                 1/1/98           0/25/457
  Nahas (27)            2012             40/38                  40/0/0            37/1/0
  Liu (28)              2013            384/384               282/63/39          310/60/14
  Kaneko (29)           2013            857/1329              625/210/22        984/310/35

We compared the minor allele to major allele in dominant, recessive, and additive models. The overall ORs and 95% CIs of −403 G/A were 1.19, 1.06--1.33 (P\<0.001) and 1.25, 1.03--1.51 (P = 0.933) in dominant and recessive models, respectively ([Figure 1](#pone-0090460-g001){ref-type="fig"},[2](#pone-0090460-g002){ref-type="fig"}). The overall ORs and 95% CIs of −28G were 1.23, 1.09--1.39 (P = 0.221) and 1.76, 1.32--2.34 (P = 0.356) in dominant and recessive models, respectively ([Figure 3](#pone-0090460-g003){ref-type="fig"},[4](#pone-0090460-g004){ref-type="fig"}) ([Table 3](#pone-0090460-t003){ref-type="table"}). Funnel plot and Egger\'s regression test showed no publication bias among studies of −403 G/A (P = 0.743 and 0.400 in dominant and recessive, respectively) and −28C/G (P = 0.435 and 0.244 in dominant and recessive, respectively).

![The association between RANTES-403G/A polymorphism and asthma in dominant model.](pone.0090460.g001){#pone-0090460-g001}

![The association between RANTES-403G/A polymorphism and asthma in recessive model.](pone.0090460.g002){#pone-0090460-g002}

![The association between RANTES −28C/G polymorphism and asthma in dominant model.](pone.0090460.g003){#pone-0090460-g003}

![The association between RANTES −28C/G polymorphism and asthma in recessive model.](pone.0090460.g004){#pone-0090460-g004}

10.1371/journal.pone.0090460.t003

###### The association between RANTES gene polymorphisms and asthma in different genetic models.

![](pone.0090460.t003){#pone-0090460-t003-3}

  Gene polymorphism    Number of studies   Genetic model    OR      95% CI     P value
  ------------------- ------------------- --------------- ------ ------------ ---------
  −403G/A                     14             Dominant      1.19   1.06--1.33   \<0.001
                                             Recessive     1.25   1.03--1.51    0.933
  −28C/G                      14             Dominant      1.23   1.09--1.39    0.221
                                             Recessive     1.76   1.32--2.34    0.356

OR: odds ratio; CI: confidence interval.

Discussion {#s4}
==========

Data of this meta-analysis showed that RANTES −403 G/A polymorphism was a risk factor for asthma, while −28C/G polymorphism were not associated with asthma.

RANTES, also known as C-C motif chemokine ligand 5 (CCL5), is a potent chemoattractant which play an important role in immune and inflammatory regulation process. The RANTES gene is located on chromosome 17q11.2-q12, which is composed of three exons and two introns. It was reported that RANTES gene polymorphisms could influence the activity of transcription and protein expression in human [@pone.0090460-Elsaadany1]. Significantly elevated concentrations of RANTES were observed in asthmatic patients, and associated with asthma severity, demonstrating the important role of RANTES in the pathogenesis of this disorder [@pone.0090460-Giuffrida1], [@pone.0090460-Isgr1], [@pone.0090460-Keskin1]. Serum RANTES may a helpful noninvasive and diagnostic marker for monitoring asthma severity. Identification and blocking of RANTES and/or its receptor may be a promising therapeutic approach to asthmatic patients [@pone.0090460-SaadElDinBessa1]. Previous investigations have reported the association of RANTES gene polymorphisms (−403G/A and −28C/G) and asthma susceptibility, however, findings of the possible relationships are remain inconsistent.

In Chinese asthmatic children population, Leung et al. [@pone.0090460-Leung1] found that RANTES −403G/A polymorphism was associated with allergen sensitization and forced expiratory volume in 1-s (FEV~1~), and no relation was observed in −28C/G polymorphism. On the contrary, numerous observations [@pone.0090460-Yao1], [@pone.0090460-Huang1], [@pone.0090460-Liu4] reported opposite conclusions showing that −28C/G polymorphism may exacerbate asthma severity. In contrast to these results, neither −403G/A nor −28C/G was indicated to be associated with asthma [@pone.0090460-Liu2], [@pone.0090460-Liu3].

In other countries, both −403G/A and −28C/G polymorphisms did not have a detectable effect on asthma susceptibility in African Americans, Lebanon, Spanish or Budapest population, respectively [@pone.0090460-Szalai1], [@pone.0090460-Moissidis1], [@pone.0090460-Muro1], [@pone.0090460-Nahas1]. However, Lachheb et al. [@pone.0090460-Lachheb1] suggested that both polymorphisms may play an important role in asthma predisposition, airway obstruction severity, or bronchial hyperresponsiveness among Tunisian or Korean children. Moreover, several investigations also demonstrated either −403G/A or −28C/G was related to asthma risk [@pone.0090460-AlAbdulhadi1], [@pone.0090460-Fryer1], [@pone.0090460-Kaneko1].

In this present study, we found that RANTES −403 G/A polymorphism was a risk factor for asthma susceptibility under dominant genetic model, indicating its potential role in asthma pathogenesis. In the meanwhile, the data also indicated that −28C/G polymorphism was not associated with asthma risk. Furthermore, no publication bias among studies was showed. Up to now, there were four meta-analysis investigations indicating controversial results about the correlation between these two polymorphisms and asthma. Three studies about the association of RANTES gene polymorphisms and asthma susceptibility reported that −28C/G polymorphism could increase the risk of asthma in Asian children or pediatric asthma in global population, while no relationship was found in −403G/A [@pone.0090460-Li1], [@pone.0090460-Lu1], [@pone.0090460-Fang1]. However, Zhang et al. [@pone.0090460-Zhang2] observed contrary findings showing that −403G/A polymorphism would be a risk factor among atopic asthma patients, and no such association was indicated in −28C/G, which is consistent with our findings. Compared with previous studies, our present study firstly provided the updated meta-analysis of comprehensive studies about RANTES gene polymorphisms and asthma.

The susceptibility of asthma might be due to the interactions of various genes (including linkage among gene polymorphisms), environment and ethnic heterogeneity factors. Therefore, larger scale studies are required to provide confirm evidence on the roles of RANTES (−403A/G and −28C/G) polymorphisms in asthma risk.

Conclusions {#s5}
===========

In summary, we concluded that RANTES −403 G/A polymorphism was a risk factor for asthma, while −28C/G polymorphism were not associated with asthma.
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